🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to collect long-term safety and efficacy data ...
Status
Recruiting
Location
City of Hope Cancer Center
Start Date
2013-09-09
Trial ID
NCT01804686
Treatments Being Tested
Primary Objectives The primary objective of this study is to evaluate the e...
Status
Unknown
Location
Klinikum der Universität München
Start Date
2016-04
Trial ID
NCT02689869
The purpose of this study is to examine the exposure and safety of a suprat...
Status
Completed
Location
Multiple Locations
Start Date
2013-10
Trial ID
NCT01969266
Treatments Being Tested
The purpose of this study is to evaluate efficacy of ibrutinib in Japanese ...
Status
Completed
Location
Anjo Kosei Hospital
Start Date
2018-05-01
Trial ID
NCT03474679
Treatments Being Tested
The purpose of this study is to evaluate overall response rate (ORR) (compl...
Status
Completed
Location
Multiple Locations
Start Date
2014-08
Trial ID
NCT02169180
Treatments Being Tested
The purpose of this study is to confirm that the pharmacokinetics of ibruti...
Status
Terminated
Location
Multiple Locations
Start Date
2016-07-01
Trial ID
NCT02703272
Treatments Being Tested
The purpose of this study is to provide continued access to treatment for p...
Status
Completed
Location
Santa Casa de Misericordia de Belo Horizonte
Start Date
2022-12-06
Trial ID
NCT05564052
Treatments Being Tested
Some cancers of the oesophagus and stomach express excessive copies of eith...
Status
Unknown
Location
The Royal Marsden NHS Trust
Start Date
2016-07-19
Trial ID
NCT02884453
Treatments Being Tested
The purpose of this study is to collect long-term safety data in participan...
Status
Enrolling By Invitation
Location
Macquarie University Hospital
Start Date
2024-12-30
Trial ID
NCT06788509
The purpose of this study is to determine the safety and recommended Phase ...
Status
Completed
Location
Rigshospitalet
Start Date
2021-07-28
Trial ID
NCT04876092
Treatments Being Tested